Advancements in aNSCLC Treatment: Highlights from WCLC 2024

17 Sept 2024Oncology

Adiya Ualiyeva

This content is sponsored. It is intended for healthcare professionals only.

Lung cancer continues to be a leading cause of cancer-related deaths in Hong Kong, with non-small cell lung cancer (NSCLC) accounting for about 82% of cases in 2021. Recent findings from the World Conference on Lung Cancer (WCLC) 2024, highlight promising advancements in the treatment of advanced NSCLC (aNSCLC).

Advancements in aNSCLC Treatment Highlights from WCLC 2024

For healthcare professionals

This sponsored content is for registered Hong Kong doctors. Log in or register to read it. If you received an access link, open it from your email.